Supplement Label Claims
Thursday, May 24, 2012
In spite of ever growing peer-reviewed clinical evidence suggesting around 90 percent of the US population suffers from nutritional deficiencies that contribute to degenerative diseases, FDA law prevents dietary supplement companies from presenting links to specific peer-reviewed clinical studies published in prestigious journals that support the use of dietary supplements to address nutrient deficiencies.
Overwhelming amounts of scientific evidence now support the fact that micronutrient deficiencies impact genomic stability, including exposure to carcinogens, DNA repair, DNA synthesis and apoptosis. Because diseases of development, degenerative diseases, and aging itself are partly controlled by damage to DNA, it seems logical that our government would direct new science to focus far more attention on redefining optimal requirements of inexpensive key vitamins, minerals and antioxidants to better address skyrocketing healthcare costs.
The list below contains a few of the most elementary and medically accepted micronutrient claims that our esteemed FDA could not deem entirely legal under current law, even though abundant published peer-reviewed science strongly suggests otherwise:
1) Vitamin C prevents and cures scurvy.
2) Vitamin D prevents and cures rickets
3) Vitamin B1 prevents and cures beri beri
4) Vitamin B3 prevents and cures pellagra
5) Vitamin B12 prevents and cures pernicious anemia
6) Folate prevents neural tube defects in the newborn.
Unfortunately, there are still no micronutrient or lifestyle choices routinely recommended by most eye doctors for cataracts, glaucoma, diabetic retinopathy, or macular degeneration prevention, despite large amounts of supporting science.
Micronutrients and genomic stability: a new paradigm for recommended dietary allowances (RDAs). Fenech, M. Food Chem Toxicol, 2002 Aug;40(8):1113-7 [ abstract]